Apheresis Medicine as a Multidisciplinary Subspecialty: International Models for Training, Quality, and Professional...

Apheresis medicine comprises a group of extracorporeal therapies essential for the management of hematologic, renal, neurologic, immunologic, transplant-related, oncologic, and critical care conditions. Advances in technology, expansion of evidence-based indications, and integration into multidisciplinary care pathways have transformed apheresis from a technical service into a clinically complex subspecialty. We conducted a narrative review of published literature and international society documentation describing models for apheresis training, professional societies, quality assurance, and regulatory interaction across high-income and resource-limited settings. Sources included peer-reviewed literature, international society guidelines, and policy documents published primarily between 2010 and 2026. Professional apheresis societies have emerged internationally to support education, quality assurance, guideline development, and workforce competency, frequently in collaboration with regulatory authorities. These societies function as scientific and educational bodies complementary to, rather than substitutive of, regulatory frameworks. Six core domains of society activity were identified: education and continuing professional development (CPD), quality and patient safety, guidelines and standards, workforce development, research and registries, and professional collaboration. Apheresis medicine has matured into a multidisciplinary clinical subspecialty requiring a dedicated professional infrastructure. International experience demonstrates that professional apheresis societies provide an evidence-based mechanism to advance education, quality assurance, and patient safety while complementing regulatory oversight. These models are generalizable across healthcare systems at varying stages of development.